Carmot Therapeutics Secures $500,159 New Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=89a05aca-f294-4f98-8102-eb4ffb58d62d&Preview=1 -
Date
7/18/2012 -
Company Name
Carmot Therapeutics -
Mailing Address
409 Illinois Street San Francisco, CA 94158 -
Company Description
Chemotype Evolution is a patent pending technology that was invented by Drs. Stig K. Hansen and Daniel A. Erlanson while they were working at Sunesis Pharmaceuticals. Carmot Therapeutics was founded by Drs. Hansen and Erlanson in 2008 with the goal of commercializing and further developing the technology. -
Website
http://www.carmot.us -
Transaction Type
Venture Equity -
Transaction Amount
$500,159 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
